Emergent BioSolutions (EBS) Free Cash Flow Growth (3y) (2013 - 2026)
Emergent BioSolutions (EBS) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 9.86% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -18.92% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 2.82% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 45.60% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 39.19% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -82.02% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 114.21% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 18.94% |
| 10 | Emergent BioSolutions | 412.09 Mn | 250.59 Mn | 84.10 Mn | 42.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.64% |
| Dec 31, 2025 | -21.18% |
| Sep 30, 2025 | 53.87% |
| Jun 30, 2025 | 53.08% |
| Mar 31, 2025 | 36.92% |
| Dec 31, 2024 | -31.70% |
| Sep 30, 2024 | 85.19% |
| Jun 30, 2024 | 33.07% |
| Mar 31, 2024 | -38.88% |
| Dec 31, 2023 | -26.61% |
| Sep 30, 2023 | -0.56% |
| Jun 30, 2023 | -51.92% |
| Mar 31, 2023 | -79.65% |
| Dec 31, 2022 | 48.80% |
| Sep 30, 2022 | -108.97% |
| Jun 30, 2022 | -1.23% |
| Mar 31, 2022 | -36.04% |
| Dec 31, 2021 | 52.02% |
| Sep 30, 2021 | -31.24% |
| Jun 30, 2021 | -97.71% |